Evidence map›Paper›PMID 20103779›Full record

ReviewBlood2010

Hematopoiesis and its disorders: a systems biology approach.

Zakary L Whichard, Casim A Sarkar, Marek Kimmel, Seth J Corey

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Why are cell populations maintained via multiple compartments?Journal of the Royal Society, Interface · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Kinetic models of hematopoietic differentiation.Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Zakary L WhichardDepartments of Pediatrics and Cell and Molecular Biology, Children's Memorial Hospital and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University School of Medicine, Chicago, IL 60611, USA.
Casim A Sarkar
Marek Kimmel
Seth J Corey
Northwestern Memorial Hospital · USSilesian University of Technology · PLUniversity of Pennsylvania · US

Funding

Collaborative Research : Stochastic Modeling and Estimation of Gene TranscriptionR01GM086885 · NIGMS · RICE UNIVERSITY · PI KIMMEL, MAREK · 2008 to 2011
$1.7M
Targeted Therapy of Lyn in Myelodysplastic SyndromeR01CA108922 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 2006 to 2010
$1.3M
Scaffolding Proteins in Macrophage PhagocytosisR01HL080052 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 2005 to 2008
$1.3M
NCI NIH HHS R01 CA108922NCI NIH HHS R01CA108922NHLBI NIH HHS R01 HL080052NHLBI NIH HHS R01HL080052NIGMS NIH HHS R01 GM086885NIGMS NIH HHS R01GM086885
6 · The paper itself

Abstract

Scientists have traditionally studied complex biologic systems by reducing them to simple building blocks. Genome sequencing, high-throughput screening, and proteomics have, however, generated large datasets, revealing a high level of complexity in components and interactions. Systems biology embraces this complexity with a combination of mathematical, engineering, and computational tools for constructing and validating models of biologic phenomena. The validity of mathematical modeling in hematopoiesis was established early by the pioneering work of Till and McCulloch. In reviewing more recent papers, we highlight deterministic, stochastic, statistical, and network-based models that have been used to better understand a range of topics in hematopoiesis, including blood cell production, the periodicity of cyclical neutropenia, stem cell production in response to cytokine administration, and the emergence of imatinib resistance in chronic myeloid leukemia. Future advances require technologic improvements in computing power, imaging, and proteomics as well as greater collaboration between experimentalists and modelers. Altogether, systems biology will improve our understanding of normal and abnormal hematopoiesis, better define stem cells and their daughter cells, and potentially lead to more effective therapies.

Indexed as

Models, BiologicalSystems BiologyHematologic DiseasesHematopoiesisHumans

Identifiers

PMID20103779
PMCPMC2845894
OpenAlexW2139425473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.